NAD+ 1g & Retatrutide - A UK Update
The growing landscape of metabolic support in the UK is seeing significant interest in the combination of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1000mg – and the novel GLP-1 receptor agonist Retatrutide (or its analogue Tirzepatide). Specialists are observing poten